IN VITRO ANALYSIS OF AKR1D1 INTERACTIONS WITH CLOPIDOGREL: EFFECTS ON ENZYME ACTIVITY AND GENE EXPRESSION
Shutevska K1*, Kadifkova Panovska T1, Zhivikj Z1, Kapedanovska Nestorovska A2
*Corresponding Author: *Corresponding Author: Kristina Shutevska, Majka Tereza 47, 1000 Skopje, Republic of North Macedonia, +389 2 1326032 (142), k.sutevska@ff.ukim.edu.mk
page: 69

MATERIALS AND METHODS

Reagents and Chemicals – Molecular Cloning Reagents: l Full-length AKR1D1 cDNA (OriGene, Rockville, MD, USA; Cat# RC223056): Used for amplify- ing and cloning the AKR1D1 gene into an expres- sion vector. l pET28b+ vector (Novagen (Merck KGaA), Darmstadt, Germany; Cat# 69865-3): Expression vector used for recombinant protein production. – Enzyme Assay Reagents: l Testosterone (Sigma-Aldrich, St. Louis, MO, USA; Cat# T1500): Substrate for AKR1D1 ac- tivity assays. l Clopidogrel Bisulfate (Sigma-Aldrich, St. Louis, MO, USA; Cat# C0612): Evaluated for interac- tions with AKR1D1 at both enzymatic and tran- scriptional levels. l 2-oxoclopidogrel (Cayman Chemical, Ann Ar- bor, MI, USA; Cat# 20394): Metabolite of clopi- dogrel tested for interactions with AKR1D1 at both enzymatic and transcriptional levels. – Cell Culture Reagents: l HepG2 Hepatocyte Cell Line (ATCC, Manassas, VA, USA; Cat# HB-8065): An in vitro model system used to study AKR1D1 expression and hepatic metabolism. l Dulbecco’s Modified Eagle Medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA; Cat# D6429): Basal medium for HepG2 cell mainte- nance. l Fetal Bovine Serum (FBS) (Capricorn Scientific, Ebsdorfergrund, Germany; Cat# FBS-12A): Sup- plemented in DMEM to support cell growth and viability. l Trypsin-EDTA Solution (Lonza, Walkersville, MD, USA; Cat# CC-5012): Used for cell detach- ment during subculturing. – MTT Assay Reagents: l MTT Solution (5 mg/mL) (Sigma-Aldrich, St. Louis, MO, USA; Cat# M2128): Used to evaluate cell viability through formazan crystal formation. l Dimethyl Sulfoxide (DMSO) (Thermo Fisher Scientific, Waltham, MA, USA; Cat# D12345): Used to dissolve formazan crystals for spectro- photometric analysis. l NADPH (Sigma-Aldrich, St. Louis, MO, USA; Cat# N7505): Essential cofactor for spectrofluo- rometric enzyme activity assays. –Expression Assay Reagents l HpaI Restriction Enzyme (New England Biolabs, Ipswich, MA, USA; Cat# R0105S): Used for linearizing the AKR1D1 plasmid to generate a calibration curve for qRT-PCR quantification. l Shrimp Alkaline Phosphatase (Takara Bio, Shiga, Japan; Cat# 2650A): Used for dephosphorylat- ing the linearized plasmid DNA to prevent self- ligation. l TRI Reagent® (Sigma-Aldrich, St. Louis, MO, USA; Cat# T9424): Used for total RNA extrac- tion from HepG2 cells. l ProtoScript® II Reverse Transcriptase (New Eng- land Biolabs, Ipswich, MA, USA; Cat# M0368): Used to synthesize complementary DNA (cDNA) from isolated RNA. l XCEED qPCR SG 2x Mix Lo-ROX (Institute of Applied Biotechnologies, Prague, Czech Repub- lic; Cat# QR0100): Used for quantitative real- time PCR analysis of AKR1D1 gene expression. l Forward and Reverse Primers (GeneriBiotech, Hradec Králové, Czech Republic): Specific prim- ers designed for the amplification of AKR1D1 during quantitative real-time PCR.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006